发明名称 LYOPHILIZED RECOMBINANT VWF FORMULATIONS
摘要 PROBLEM TO BE SOLVED: To provide stable pharmaceutical formulations comprising recombinant von-Willebrand Factor (rVWF).SOLUTION: The present invention provides formulations useful for lyophilization of recombinant VWF, resulting in a highly stable pharmaceutical composition. The stable pharmaceutical composition is useful as a therapeutic agent in the treatment of individuals suffering from disorders or conditions that can benefit from the administration of recombinant VWF. In one embodiment, a stable lyophilized pharmaceutical formulation of recombinant rVWF is provided comprising: (a) a rVWF; (b) one or more buffering agents; (c) one or more amino acids; (d) one or more stabilizing agents; and (e) one or more surfactants.SELECTED DRAWING: None
申请公布号 JP2016106124(A) 申请公布日期 2016.06.16
申请号 JP20160035672 申请日期 2016.02.26
申请人 BAXTER INTERNATL INC;BAXTER HEALTHCARE SA 发明人 KURT SCHNECKER;EVA HAIDWEGER;PETER TURECEK
分类号 A61K38/43;A61K9/19;A61P7/04;A61P43/00 主分类号 A61K38/43
代理机构 代理人
主权项
地址